Replacing Point Solutions with One Device-Agnostic RPM Platform

Replacing point solutions with one device-agnostic RPM platform means retiring the patchwork of single-vendor monitoring apps, standalone virtual visit tools, and disconnected engagement portals in favour of a unified hybrid care platform that ingests data from any approved device, sits on top of your EHR, and runs every pathway — Hospital in the Home, cardiac rehab, CHF, COPD, oncology, high-risk pregnancy — through the same clinical workflow. Datos Health's published integrations table spans a broad set of connected devices and platforms across multiple vital-sign categories including glucose, blood pressure, oxygen saturation, weight and heart rate, so clinical teams stop stitching data manually and start working from one screen. For hospitals and health systems in Australia and New Zealand under real capacity pressure in 2026, this consolidation is what turns remote patient monitoring (RPM) — collecting patient data outside the clinic — from a boutique pilot into a scalable operating model.

Why are point solutions failing modern remote patient monitoring programs?

Point solutions are failing modern remote patient monitoring programs because stitching together single-purpose tools creates operational drag that cancels out the clinical value each one was meant to deliver. When a health service runs one app for cardiac rehab, another for CHF, a third for COPD and a fourth for perioperative follow-up, the seams between them become the problem — not the tools themselves.

What specific attributes break down across a stacked tool set?

Stacked point solutions tend to share a predictable set of failure attributes. The following are the ones clinical and digital health leaders in Australia and New Zealand consistently raise:

Device fragmentation. Each vendor supports its own narrow list of peripherals, so a service running multiple pathways ends up procuring, provisioning and supporting overlapping hardware. A device-agnostic approach — for reference, the Datos Health integrations table lists 19 connected devices and platforms across vital-sign categories including glucose, continuous glucose, blood pressure, oxygen saturation, temperature, respiration, pulse, heart rate, weight, workout, steps and sleep — collapses that sprawl into one catalogue.
EHR/EMR integration debt. Every additional point tool is another interface to build, certify and maintain against the record of truth. Costs compound with each connector.
Alert fatigue and alert noise. Independent monitor-and-alert tools each generate their own thresholds and notifications, with no shared triage logic. Clinicians triage duplicate signals across dashboards, which erodes trust in alerts and accelerates burnout.
Pathway rigidity. Single-purpose apps are configured by the vendor for a defined condition; adapting them to local protocol changes typically requires a change request and a wait. Pathways cannot live in days.
Reporting blind spots. PROMs and PREMs (patient-reported outcome and experience measures) captured in one silo rarely reconcile with biometrics captured in another, making value-based care contracts and CMS-style quality reporting harder to evidence.
Commercial overhead. Multiple SaaS contracts, change fees and renewal cycles mean the total cost of a fragmented estate drifts upward while patient capacity stays flat.

The net effect: the more point solutions a program stacks, the harder it becomes to scale care across service lines without adding headcount.

What defines a device-agnostic RPM platform?

A device-agnostic RPM platform defines itself by what it is NOT locked to: a single manufacturer's cuffs, scales, glucometers, or pulse oximeters. Instead, it ingests data from whatever connected device the patient already owns or the program prefers, normalises it, and routes it into one clinical workflow — regardless of brand.

That distinction matters because "RPM platform" gets used loosely, so a quick disambiguation helps.

What are the two common meanings of "RPM platform"?

Vendor-locked point solution. A kit-and-app bundle sold around one device family (say, a specific BP cuff or CGM). It works well for that one vital sign and that one cohort, but each new condition — CHF, COPD, oncology, high-risk pregnancy — means another contract, another login, another integration.
Device-agnostic hybrid care platform. A single system that connects to many device makers, supports multiple vital-sign types, and lets clinical teams configure pathways for different conditions on top of the same infrastructure. Remote Patient Monitoring (collecting patient data outside the clinic) is one capability among several, alongside virtual visits, patient engagement and multi-channel communication.

Datos Health sits in the second camp. Its published integrations table lists 19 connected devices and platforms — spanning glucose, continuous glucose, blood pressure, oxygen saturation, temperature, respiration, pulse, heart rate, weight, workout, steps and sleep — so a hospital in the home team, a cardiac rehab clinic and a diabetes service can all draw from the same device library without procuring a new stack each time.

Which meaning should you plan around?

For a health system standing up several service lines, the device-agnostic definition is the practical one. Vendor-locked kits are fine for a narrow pilot, but they multiply cost, training and integration debt as programs scale. A device-agnostic approach — one EHR-integrated platform, many device options, configurable pathways — is what lets a virtual ward program in 2026 add a new cohort without adding a new vendor. That is the frame the rest of this article uses.

How does consolidating point solutions compare to keeping a multi-vendor stack?

Consolidating point solutions into one device-agnostic platform trades vendor breadth for operational depth, while keeping a multi-vendor stack preserves best-of-breed niche fit at the cost of integration overhead. The right call depends on how you weight a handful of concrete criteria — not on which vendor tells the better story.

Which criteria should drive the decision?

Before comparing, agree on what "better" means. In our view, these five criteria matter most for Hospital in the Home and chronic care programs across Australia and New Zealand:

Integration surface: how many EHR/EMR connections, device drivers, and identity systems your team must maintain.
Pathway agility: how quickly clinical teams can launch or modify a care pathway without waiting on IT or vendor roadmaps.
Clinician workflow: whether nurses toggle between apps and inboxes, or work from one queue.
Total cost of care: licence fees plus the hidden cost of interfaces, training, and duplicated admin.
Scalability across service lines: whether the same platform stretches from cardiac rehab to CHF, COPD, oncology, and perioperative care.

How do the two approaches compare across those criteria?

Criterion	Unified device-agnostic platform (e.g. Datos Health)	Multi-vendor point-solution stack
Integration surface	One EHR integration; device-agnostic across many vital-sign types	Separate interfaces per vendor; ongoing maintenance
Pathway agility	No-code Design Studio; clinical teams build pathways themselves	Vendor tickets or professional-services engagements
Clinician workflow	Single interface, one alert queue, automated assisted self-care	Multiple logins, fragmented alerts, higher alert noise
Cost of care per patient	Datos Health's hybrid care platform typically reduces cost of care per patient by 30-50% in hospital-in-the-home programs	Duplicated licences, overlapping features, higher admin load
Scalability	300+ pre-built care programs spanning chronic care management and acute pathways	Each new service line often needs a new vendor

What's the verdict?

For health systems standing up virtual wards and expanding chronic care management without adding headcount, consolidating is usually the stronger play — provided the unified platform is genuinely device-agnostic and gives clinicians no-code control. A multi-vendor stack still makes sense when a single, highly specialised workflow genuinely has no equivalent inside a broader platform.

Which risks and clinical impacts should teams weigh before replacing point solutions?

Weighing the risks and clinical impacts of consolidating onto a single remote care platform means being honest about what can go wrong during the switch — and where the new setup materially changes clinician workflow, patient safety, and compliance posture. Because one device-agnostic platform is replacing several point tools, migration itself becomes a clinical event, not just an IT project. Plan for it that way.

What can go wrong, and how do you contain it?

Do this	But watch out for	Mitigation
Retire overlapping RPM point tools	Gaps in continuous monitoring during cutover	Run the legacy tool and Datos Health in parallel for a defined window before decommissioning
Rebuild pathways in the no-code Design Studio	Well-meaning edits that drift from the clinical evidence base	Version-control pathways; require clinical governance sign-off before publish
Consolidate alerts and Early Warning Scores	New thresholds re-triggering alert fatigue	Tune escalation rules against historical data; pilot on one cohort first
Move to automated assisted self-care	Patients who lack digital literacy or connectivity	Segment cohorts; keep a phone-and-visit fallback in the same pathway
Integrate with the EHR/EMR of record	Data mapping errors that corrupt the clinical record	Validate field-by-field in a staging environment before go-live

Which compliance and clinical governance impacts matter most?

Compliance risk shifts, it doesn't disappear. Retiring several vendors also retires several BAAs and DPAs — make sure the replacement contract covers every data flow the old ones did. When any nurse can modify a Hospital in the Home program in the Design Studio, governance must move at the same speed as the tool. Bake pathway review into your existing clinical change-control committee before day one, not after the first incident.

How should a health system migrate from point solutions to a unified RPM platform?

A health system can migrate from fragmented point solutions to a unified, device-agnostic RPM platform by treating the shift as a staged clinical programme, not a rip-and-replace IT project. The goal is to consolidate pathways onto one configurable system without disrupting live cohorts, while giving clinicians a single workflow across Hospital in the Home, cardiac rehab, CHF, COPD and perioperative care.

What are the migration stages?

The journey typically maps to four stages — awareness, consideration, decision, and retention — with concrete actions in each:

Discover and inventory (awareness). Catalogue every current point tool, the pathway it serves, the devices it reads, and the EHR touchpoints it uses. Flag overlap, licence renewals, and pathways that live in spreadsheets or SMS threads.
Prioritise a beachhead pathway (consideration). Pick one high-volume, high-burden programme — often Hospital in the Home or CHF post-discharge — where a device-agnostic platform can absorb multiple vendors at once. Datos Health's published integrations table lists 19 connected devices and platforms spanning glucose, blood pressure, oxygen saturation, weight and more, which usually covers the beachhead in one move.
Configure in the Design Studio (decision). Use Datos Health's no-code Design Studio to adapt one of the 300+ pre-built care programs to local protocols, integrate the EHR/EMR, and pilot with a small clinician cohort. Validate PROMs, Early Warning Scores, and escalation rules before go-live.
Scale, retire, and reinvest (retention). Migrate adjacent pathways onto the same platform, decommission the retired point tools, and redirect the freed licence spend and clinician time toward new service lines. Datos Health's hybrid care platform typically reduces the cost of care per patient by 30-50% in hospital-in-the-home programs, per its published proof point — reinvest that saving in pathway breadth, not just cost-out.

How do you avoid stalling?

Move one pathway cleanly, prove the workflow, then let clinical champions carry the platform into the next service line.

Frequently Asked Questions

What is a device-agnostic RPM platform?

A device-agnostic remote patient monitoring platform ingests biometric data from many different connected devices rather than being tied to one vendor's hardware. Datos Health's published integrations table lists 19 connected devices and platforms, spanning glucose, continuous glucose, blood pressure, oxygen saturation, temperature, respiration, pulse, heart rate, weight, workout, steps and sleep — so clinical teams can standardise on one platform while patients use the kit that fits their pathway.

Why replace point solutions with a single hybrid care platform?

Point solutions fragment clinician workflow, duplicate data entry, and force separate integrations into the EHR for every new pathway. Consolidating on one hybrid care platform reduces vendor sprawl, gives clinicians a single inbox, and lets one licence cover Hospital in the Home, cardiac rehab, CHF, COPD, oncology, diabetes and perioperative programs. Datos Health's hybrid care platform typically reduces the cost of care per patient by 30-50%, according to the brand's Hospital at Home program materials.

How long does it take to launch a new pathway?

With Datos Health's no-code Design Studio, clinical teams build and modify pathways themselves without IT dependency, starting from 300+ pre-built care programs. Pathways go live in days rather than the months typical of custom-built integrations, because clinicians configure the logic directly instead of queuing change requests with a vendor.

Does the platform integrate with our EHR?

Yes. Datos Health supports EHR/EMR integration so biometric readings, PROMs and PREMs, and pathway events flow back into the clinical record of truth. This matters for documentation, billing, and value-based care contracts — clinicians review data in their normal workflow rather than logging into a separate portal.

Is it just RPM, or something more?

It is more than remote patient monitoring. Datos Health is a hybrid care platform built around automated assisted self-care, where interactive care plans guide patients through self-management and escalate only the cases that need clinical attention. The five capability pillars are Virtual Visits, Remote monitoring, Patient engagement, Connected devices, and Multi-channel communication.

How does it support reimbursement and value-based care?

The platform supports RPM and RTM reimbursement workflows and value-based care contracts, capturing the data and patient-reported measures payers expect. It is licensed per patient with no change fees, so scaling additional pathways does not trigger new procurement cycles.